Autres langues Monopar Therapeutics Inc.

Actions

MNPR

US61023L1089

Temps réel estimé Cboe BZX Autres places de cotation 20:13:42 15/05/2024			Varia. 5j.	Varia. 1 janv.
0,643 ^USD	-1,23 %		-14,52 %	+88,45 %

09/05	Monopar Therapeutics Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
16/04	Monopar Therapeutics Inc. annonce le dépôt d'un brevet protégeant les résultats de l'optimisation de la radiopharmacie MNPR-101	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline	09/05
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting	18/04
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting	18/04
Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct	16/04
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings	16/04
Monopar Therapeutics Inc. Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings	16/04
North American Morning Briefing : Big Banks Kick -2-	12/04
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients	10/04
Monopar Therapeutics Inc Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients	10/04
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments	28/03
Monopar Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments	28/03
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program	05/03
Monopar Therapeutics Inc. Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program	05/03
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial	27/02
Sector Update: Health Care Stocks Gain Late Afternoon	22/02
Sector Update: Health Care	22/02
Monopar Therapeutics Shares Rise on 'Promising' Preclinical Cancer Treatment Trial Results	22/02
Top Midday Gainers	22/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Monopar Therapeutics Inc.

Actions

MNPR

US61023L1089

Autres langues

Filtres